Takuya Kobayakawa - Concepedia

Author

Takuya Kobayakawa

Tokyo Medical and Dental University ORCID

Also Known As

Kobayakawa, T., Takuya Kobayakawa

Publications

663

Citations

H-Index

Concepts

All Affiliations

Tokyo Medical and Dental University National Institute of Infectious Diseases National Center for Global Health and Medicine Kumamoto University National Institutes of Health

About

Takuya Kobayakawa is an author at Tokyo Medical and Dental University specializing in biomolecular engineering, chemistry, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Biomolecular Engineering	6	6	116
2	Engineering	5	5	96
3	Medicine	4	4	66
4	Natural Sciences	3	3	56
5	Biochemistry	1	1	16

Takuya Kobayakawa

Publications

432

Citations

H-Index

Page 1

	Year	Citations
Identification of SARS-CoV-2 Mpro inhibitors containing P1’ 4-fluorobenzothiazole moiety highly active against SARS-CoV-2 Nobuyo Higashi‐Kuwata, Kohei Tsuji, Hironori Hayashi, Nature Communications	2023	44
Benzolactam-related compounds promote apoptosis of HIV-infected human cells via protein kinase C–induced HIV latency reversal Kouki Matsuda, Takuya Kobayakawa, K. Tsuchiya, Journal of Biological Chemistry	2018	38
Remote Stereoinduction in the Organocuprate-Mediated Allylic Alkylation of Allylic <i>gem</i>-Dichlorides: Highly Diastereoselective Synthesis of (<i>Z</i>)-Chloroalkene Dipeptide Isosteres Takuya Kobayakawa, Tetsuo Narumi, Hirokazu Tamamura Organic Letters Asymmetric CatalysisCross-coupling ReactionNovel OrganocatalystsEngineeringOrganocuprate-mediated Allylic Alkylation	2015	29
Stereoselective Formation of Trisubstituted (<i>Z</i>)-Chloroalkenes Adjacent to a Tertiary Carbon Stereogenic Center by Organocuprate-Mediated Reduction/Alkylation Tetsuo Narumi, Takuya Kobayakawa, Haruo Aikawa, Organic Letters Novel 1,4-Asymmetric InductionOrganocuprate-mediated Reduction/alkylationDerivativesEngineeringStereoselective Formation	2012	26
Soluble-type small-molecule CD4 mimics as HIV entry inhibitors Takuya Kobayakawa, K Konno, Nami Ohashi, Bioorganic & Medicinal Chemistry Letters Human RetrovirusImmunologyAntiviral Drug DevelopmentAntiviral ResponseHiv	2019	23
Structure–Activity Relationship Studies of SARS-CoV-2 Main Protease Inhibitors Containing 4-Fluorobenzothiazole-2-carbonyl Moieties Kohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, Journal of Medicinal Chemistry	2023	23
Synthesis of a Chloroalkene Dipeptide Isostere-Containing Peptidomimetic and Its Biological Application Takuya Kobayakawa, Yudai Matsuzaki, Kentaro Hozumi, ACS Medicinal Chemistry Letters	2017	21
Potent and biostable inhibitors of the main protease of SARS-CoV-2 Kohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, iScience	2022	21
Design, synthesis and biological evaluation of low molecular weight CXCR4 ligands Maxwell Sakyiamah, Takuya Kobayakawa, Masayuki Fujino, Bioorganic & Medicinal Chemistry Drug DiscoveryBiological EvaluationBiomolecular EngineeringChemistry	2019	20
Small-Molecule Anti-HIV-1 Agents Based on HIV-1 Capsid Proteins Takuya Kobayakawa, Masaru Yokoyama, Kohei Tsuji, Biomolecules ImmunologyMolecular BiologyAntiviral DrugViral Structural ProteinChemical Biology	2021	16

Page 1